GL1X · GenesisL1 explorer

Research workbench

HIV reverse transcriptase in complex with inhibitor 7E (nnrti)

Analyse HIV reverse transcriptase in complex with inhibitor 7E (nnrti) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2RF2
Type
protein
Length
959 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse TRANSCRIPTASE/RIBONUCLEASE H (ec 2.7.7.49) (ec 2.7.7.7) (ec 3.1.26.4) (P66 rt)
EC
2.7.7.49
UniProt
P04585
Ligands
MRX
Pockets
15 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReverse TRANSCRIPTASE/RIBONUCLEASE H (ec 2.7.7.49) (ec 2.7.7.7) (ec 3.1.26.4) (P66 rt) (EC 2.7.7.49)protein55432% helix, 23% strandP04585
BReverse TRANSCRIPTASE/RIBONUCLEASE H (ec 2.7.7.49) (ec 2.7.7.7) (ec 3.1.26.4) (P66 rt) (EC 2.7.7.49)protein40538% helix, 19% strandP04585

Ligands and binding sites

  • MRX · 5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18830.800.8291MRX
24760.680.7937empty
32980.660.8137empty
42680.650.8239empty
54240.650.7850empty

Interfaces

1 interface between chains.

  • A–B · 2663 Ų buried · 25 hydrogen bonds · protein-protein

Compared structures

  • 2RF2 · HIV reverse transcriptase in complex with inhibitor 7e (NNRTI) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.